SCHEMBL8267813

SCHEMBL8267813

CCC(=O)C1(C2=CC=CCC2)CCN(C(=O)c2cnc(N3CCOCC3)nc2-c2ccccc2F)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 2/20 0.39
▸ BCR P11274 2/20 0.39
▸ PDE4B Q07343 4/20 0.39
▸ LMNA P02545 2/20 0.37
▸ HTT P42858 1/20 0.36
▸ PTPN11 Q06124 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ PIK3R1 P27986 2/20 0.34
▸ PIK3CA P42336 2/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ CYP2C9 P11712 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ CASP7 P55210 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ ALOX5AP P20292 1/20 0.34
▸ FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11923202 0.87 ABL1 (0.43) ABL1BCRPDE4BLMNAHTT
SCHEMBL8267844 0.80 ABL1 (0.53) ABL1BCRPDE4BLMNAHTT
SCHEMBL8268278 0.78 ABL1 (0.52) ABL1BCRPDE4BLMNAHTT
SCHEMBL8267373 0.78 ABL1 (0.51) ABL1BCRPDE4BLMNAHTT
SCHEMBL11923375 0.76 KDM4E (0.48) ABL1BCRPDE4BLMNAHTT
SCHEMBL8266816 0.75 ABL1 (0.48) ABL1BCRPDE4BLMNAHTT
SCHEMBL8267648 0.74 PDE4B (0.49) ABL1BCRPDE4BLMNAHTT
SCHEMBL8267367 0.74 ABL1 (0.45) ABL1BCRPDE4BLMNAHTT
SCHEMBL2948308 0.73 PTPN11 (0.52) ABL1BCRLMNAPTPN11TP53
SCHEMBL2951241 0.73 KDM4E (0.52) TP53ALDH1A1HSD17B10AOC3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006050476-A2 PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-05-11 — — WO disclosed
Send feedback